|
ZNF197 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.392100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.010300E-02 |
| Normal-vs-Stage2 |
3.283000E-01 |
| Normal-vs-Stage3 |
4.263400E-03 |
| Normal-vs-Stage4 |
5.238000E-02 |
| Stage1-vs-Stage2 |
9.264200E-01 |
| Stage1-vs-Stage3 |
2.138200E-01 |
| Stage1-vs-Stage4 |
5.851800E-01 |
| Stage2-vs-Stage3 |
4.192200E-01 |
| Stage2-vs-Stage4 |
6.722000E-01 |
| Stage3-vs-Stage4 |
8.056000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.356400E-02 |
| Normal-vs-AfricanAmerican |
5.171700E-02 |
| Normal-vs-Asian |
4.448800E-01 |
| Caucasian-vs-AfricanAmerican |
6.950600E-01 |
| Caucasian-vs-Asian |
8.725200E-01 |
| AfricanAmerican-vs-Asian |
7.751200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.983100E-04 |
| Normal-vs-Female |
4.305000E-01 |
| Male-vs-Female |
1.972790E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.258600E-01 |
| Normal-vs-Extreme_Weight |
1.976930E-03 |
| Normal-vs-Obese |
2.347000E-01 |
| Normal-vs-Extreme_Obese |
4.469500E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.760990E-01 |
| Normal_Weight-vs-Obese |
8.701800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.707000E-01 |
| Extreme_Weight-vs-Obese |
8.627900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.946000E-01 |
| Obese-vs-Extreme_Obese |
3.893200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.411600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.596800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.122900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.485600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.704600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.143600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.983800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.740100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.289200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.946800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.124100E-02 |
| Normal-VS-Type2 PRCC |
1.87659999995038E-06 |
| Normal-VS-KIRP CIMP |
9.523800E-01 |
| Normal-VS-Unclassified PRCC |
8.544000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.51789999999608E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.663600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.491200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.149600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.236400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.417600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.00299999999687E-05 |
| Normal-vs-N1 |
8.516200E-02 |
| Normal-vs-N2 |
6.132800E-01 |
| N0-vs-N1 |
5.803900E-02 |
| N0-vs-N2 |
2.051200E-01 |
| N1-vs-N2 |
7.394400E-01 |
|
|
